PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
01-Feb-2024 EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO EnteroBiotix
01-Feb-2024 Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board Lindus Health
31-Jan-2024 OKYO Pharma Announces Distinguished Ophthalmologists with Expertise in the Medical and Surgical Treatment of Ocular Surface Diseases Join its Scientific Advisory Board OKYO Pharma Limited
31-Jan-2024 Almirall and Microsoft announce partnership for digital transformation to enable the development of novel treatments for skin diseases Almirall
31-Jan-2024 AAVantgarde appoints Nina (Ekaterini) Kotsopoulou, Ph.D., as Chief Technical Officer AAVantgarde Bio
31-Jan-2024 MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19 MetrioPharm
31-Jan-2024 New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe BellaSeno GmbH
30-Jan-2024 Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman Huxley Health Inc
30-Jan-2024 ABPI welcomes Labour's life sciences plan ABPI
30-Jan-2024 Fabentech awarded €7.7m from the European Commission as coordinator of the e FabRIC consortium to develop an innovative broad-spectrum therapy against emerging viruses with pandemic potential Fabentech
30-Jan-2024 Axplora invests €8 million in Le Mans to further expand its capacity for antibody drug conjugate manufacturing Axplora
30-Jan-2024 OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry OPEN X Health
30-Jan-2024 HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer HUTCHMED
30-Jan-2024 Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release Cresset
30-Jan-2024 RECOMMENDED ALL-SHARE ACQUISITION OF THE ASSETS OF ARIX BIOSCIENCE PLC ("Arix") RTW BIOTECH OPPORTUNITIES LTD ("RTW Bio")
29-Jan-2024 Aripiprazole once-every-two-months long-acting injectable recommended for approval in the EU by the CHMP for the maintenance treatment of schizophrenia in adult patients stabilised with aripiprazole Otsuka Pharmaceutical
29-Jan-2024 Update on Regulatory Review of leriglitazone in the EU Minoryx Therapeutics
29-Jan-2024 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR TIRZEPATIDE (MOUNJARO ®▼) IN ALTERNATIVE KWIKPEN® PRESENTATION FOR TWO INDICATIONS Lilly
29-Jan-2024 Cherwell launches Redipor® Beta Bags to support continuous manufacturing of sterile medicinal products Cherwell
26-Jan-2024 Cognizant Helping to Modernise Infrastructure and Application Management as Part of Takeda’s Digital Transformation Cognizant